ABSTRACT

Introduction
Due to Western Australia's large geographic size and low rural population density few breast imaging diagnostic services are available outside the metropolitan area. BreastScreen WA offers population mammographic screening via fixed clinics in the metropolitan area and mobile clinics that visit country areas every two years. If an abnormality is suspected following mobile clinic screening, women undergo Step Down Assessment; diagnostic further views are performed at the mobile clinic and if a possibly significant abnormality persists, country women are referred to a Perth Metropolitan Breast Assessment Centre. The purpose of this retrospective cohort study was to determine if Step Down Assessment in country Western Australia offered women the same diagnostic effectiveness as screening and assessment in the metropolitan area.
Methods
The study used all screening episodes at BreastScreen WA between 1999 and 2008. Screening episodes from metropolitan and mobile clinics were compared according to the primary outcomes of cancer detection rates, recall and further investigations, cancer size, return to screen rates and interval cancers.
Results
Overall, the cancer detection rate per 1000 screening episodes was lower for the country program than the metropolitan program (3.07 (2.84-3.31) versus 7.04 (6.82-7.27)). The false negative (interval cancer) rate was lower for Step Down Assessment than for the metropolitan program. The size of cancers detected was the similar for both screening services. Return to screen rates were comparable between both groups.
Conclusion
The results indicate that the current service model is providing appropriate diagnostic effectiveness as well as comparable client satisfaction, for country and metropolitan women.
INTRODUCTION
BreastScreen WA has been part of the national BreastScreen Australia program since 1991 (1) . Only 30% of West Australians reside outside the metropolitan area and generally experience lower access to health-care services than their metropolitan counterparts (2).
Due to Western Australia's large geographic size and low rural population density few breast imaging diagnostic services are available outside the metropolitan area. Women residing in rural areas often have to travel hundreds of kilometres to access breast diagnostic services. While the overall effectiveness of population mammographic screening in Western Australia has been demonstrated (3), the purpose of this study is to determine if women in country and metropolitan locations are benefiting to the same degree from the screening services offered by BreastScreen WA. evaluated. This data included the number of women screened, the number of women receiving DFVs, the number of women receiving further investigations, the number of invasive cancers detected, the size of detected cancers, the number of women returning to screen within 27 months and the number of interval cancers. An interval cancer is defined as "the number of invasive breast cancers detected in women screened through BreastScreen Australia that arise during an interval between two screening rounds, per 10 000 women years."(4) Only women aged 50-67 were included in the rescreen rate as only they remained in the target age group 27 months after their index screen. The screening interval of 27 months is used instead of the recommended 2 year interval to allow for potential delays in screening availability and data transfer.
Women who attend for annual screening are included in the study. Rural women who screen annually with the program will have one of their screens at Perth, every two years.
This will not affect the return to screen rate, interval cancer rate or cancer detection rates as only the site of screening is differentiated only for the index screen not the subsequent screen.
Data analysis
Outcomes of screening for country and metropolitan locations were compared for percentage of screens going on to DFVs and further investigations; cancer detection rate overall and among screens going on to DFV and further investigation; average cancer size; interval cancer rate; and return to screen within 27 months overall and among screens going on to DFV and further investigation. All rates are not age standardised. 
RESULTS
The study included a total of 760 027 screening episodes. 71.8% of screening episodes took place at a metropolitan clinic and 28.2% at a rural location.
Overall, the cancer detection per 1000 screening episodes was lower for the country program than the metropolitan program (3.07 (2.84-3.31) versus 7.04 (6.82-7.27)) ( Table 1) .
Sensitivity of cancer detection at the metropolitan clinic was 0.91 and at the country clinic 0.95. Sensitivity was calculated by dividing the number of cancers detected by the number of cancers detected plus the interval cancer rate.
Conversely, the rate of cancer detection among women recalled for assessment after a DFV Recall rates following a screening mammogram were comparable between country and metropolitan women (Table 2) . A country woman recalled for assessment was more likely to have a DFV only and be returned to routine biennial screening (62.4%) than to be referred for additional investigations (37.6%). Conversely among metropolitan women recalled for assessment, 29.6% received a DFV only and 70.4% were referred for additional investigations. Country women recalled to the BreastScreen van for DFVs were less likely than metropolitan women to go on to additional diagnostic procedures (37.6% (36.4-38.4) versus 70.4% (69.9-70.9)). Of particular note, metropolitan women receive more ultrasounds than country women (54.2% vs. 26.4%).
The average size of screen detected cancers was similar for country and metropolitan The reasons for the higher rate of breast cancer among the metropolitan women included in this study are currently unknown. Without data matching, underlying differences between country and metropolitan women in terms of age and menopausal status may be contributing to the differences in cancer detection rates between the two groups. Although an Australia wide study showed that country women were less likely than metropolitan women to participate in mammographic screening programs (7) this is not the case in Western Australia. BreastScreen WA data shows that metropolitan and country programs are achieving similar rates of participation within the target age range of 50-69 years (56.5% vs 59.3% in 2005) (1). The results of our study showed the average size of cancers detected at metropolitan and country clinics to be comparable.
Country women are receiving fewer investigations overall without compromising cancer detection rates. This likely reflects the higher incidence of significant abnormalities present in metropolitan women who require more work up. It would appear that metropolitan women are being subjected to a degree of opportunistic screening ultrasound examinations while at the BAC. A formal economic analysis of the metropolitan and country programs has not been conducted and would provide valuable information regarding their comparative cost effectiveness. Previous research has suggested that high use of assessment investigations may increase anxiety associated with screening without conferring benefit in terms of accuracy of assessment (8, 9) . Despite this consideration, rescreen participation rates are comparable between metropolitan and country women irrespective of how extensively they are investigated before being returned to the routine biennial screening schedule. This suggests that both groups are equally satisfied with the service provided to them; however, a qualitative study examining the attitudes of country and metropolitan West Australian women towards the Step Down Assessment and standard assessment procedures would provide more evidence on this matter.
CONCLUSION
This study described the Step Down Assessment process provided to country women by BreastScreen WA. The diagnostic effectiveness of Step Down Assessment was compared to that of the standard screening and assessment protocol offered to metropolitan women.
The study found that Step Down Assessment lead to the detection of cancers at a comparable size to the standard metropolitan screening and assessment protocol and was associated with a lower false negative (interval cancer) rate. The lower cancer detection rate in rural versus metropolitan women was attributed to lower cancer incidence rates for rural versus metropolitan women in Australia (6). These findings support the continuation of the
Step Down program as an effective way to deliver breast cancer screening and assessment in country areas without the need for women to travel thousands of kilometres for assessment at a metropolitan clinic. 
